Adam Elsesser is the Chief Executive Officer and Chairman of Penumbra, Inc., a global healthcare company specializing in innovative technologies that address challenging medical conditions such as stroke and vascular diseases. He co-founded Penumbra in 2004 and has led the company through significant growth, including its successful initial public offering in 2015. Under his leadership, Penumbra has become a leader in interventional therapies, particularly in neurovascular and vascular interventions, and has expanded into new areas such as immersive therapeutic platforms for rehabilitation. Elsesser is recognized for his entrepreneurial vision and commitment to advancing patient care through technological innovation.